M
Muralidhar Pallaki
Researcher at Case Western Reserve University
Publications - 7
Citations - 563
Muralidhar Pallaki is an academic researcher from Case Western Reserve University. The author has contributed to research in topics: Placebo & Psychological intervention. The author has an hindex of 5, co-authored 5 publications receiving 442 citations. Previous affiliations of Muralidhar Pallaki include Veterans Health Administration & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Effect of Vitamin E and Memantine on Functional Decline in Alzheimer Disease The TEAM-AD VA Cooperative Randomized Trial
Maurice W. Dysken,Mary Sano,Sanjay Asthana,Julia E. Vertrees,Muralidhar Pallaki,Muralidhar Pallaki,Maria D. Llorente,Susan Love,Gerard D. Schellenberg,J. Riley McCarten,Julie Malphurs,Susana Prieto,Peijun Chen,Peijun Chen,David Loreck,David Loreck,George Trapp,Rajbir S. Bakshi,Jacobo Mintzer,Jacobo Mintzer,Judith L. Heidebrink,Ana Vidal-Cardona,Lillian M. Arroyo,Angel R. Cruz,Sally B. Zachariah,Neil W. Kowall,Mohit P. Chopra,Suzanne Craft,Stephen Thielke,Carolyn Turvey,Carolyn Turvey,Catherine Woodman,Catherine Woodman,Kimberly A. Monnell,Kimberly Gordon,Julie Tomaska,Yoav Segal,Peter Peduzzi,Peter Peduzzi,Peter Guarino,Peter Guarino +40 more
TL;DR: Benefit of alpha tocopherol in mild to moderate AD is suggested by slowing functional decline and decreasing caregiver burden.
Journal ArticleDOI
Vitamin E and memantine in Alzheimer's disease: Clinical trial methods and baseline data
Maurice W. Dysken,Peter Guarino,Julia E. Vertrees,Sanjay Asthana,Mary Sano,Maria D. Llorente,Muralidhar Pallaki,Susan Love,Gerard D. Schellenberg,J. Riley McCarten,Julie Malphurs,Susana Prieto,Peijun Chen,David Loreck,Sara Carney,George Trapp,Rajbir S. Bakshi,Jacobo Mintzer,Judith L. Heidebrink,Ana Vidal-Cardona,Lillian M. Arroyo,Angel R. Cruz,Neil W. Kowall,Mohit P. Chopra,Suzanne Craft,Stephen Thielke,Carolyn Turvey,Catherine Woodman,Kimberly A. Monnell,Kimberly Gordon,Julie Tomaska,Govind T. Vatassery +31 more
TL;DR: A clinical trial was designed to compare the effectiveness of alpha‐tocopherol, a vitamin E antioxidant; memantine (Namenda), an N‐methyl‐D‐aspartate antagonist; their combination; and placebo in delaying clinical progression in AD.
Journal ArticleDOI
Neuropsychiatric Symptoms and Caregiver Burden in Individuals With Alzheimer's Disease: The TEAM-AD VA Cooperative Study.
Peijun Chen,Peijun Chen,Peter D. Guarino,Maurice W. Dysken,Muralidhar Pallaki,Muralidhar Pallaki,Sanjay Asthana,Maria D. Llorente,Maria D. Llorente,Susan Love,Julia E. Vertrees,Gerard D. Schellenberg,Mary Sano +12 more
TL;DR: Neuropsychiatric symptoms were prevalent in both mild and moderate AD, even in patients receiving treatment with an acetylcholinesterase inhibitors, and were more severe in moderate AD and associated with greater caregiver time.
Journal ArticleDOI
General principles of hypertension management in the elderly.
TL;DR: Because the elderly have multiple comorbid concomitant conditions, the practitioner must be cognizant of polypharmacy and resistant HTN and prescribe in a safe fashion conducive to compliance and efficacy.
Journal ArticleDOI
Measuring informed consent capacity in an Alzheimer's disease clinical trial
Peter D. Guarino,Julia E. Vertrees,Sanjay Asthana,Mary Sano,Maria D. Llorente,Maria D. Llorente,Muralidhar Pallaki,Muralidhar Pallaki,Susan Love,Gerard D. Schellenberg,Maurice W. Dysken +10 more
TL;DR: Accurately and efficiently determining a participant's capacity to consent to research is critically important to protect the rights of patients with Alzheimer's disease (AD).